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ABSTRACT  1 
Background: Ireland has traditionally operated a liberal policy of voluntary fortification but 2 
little is known about how this practice, along with supplement use, affects population intakes 3 
and status of folate and vitamin B-12.  4 
Objective: To examine the relative impact of voluntary fortification and supplement use on 5 
dietary intakes and biomarker status of folate and vitamin B-12 in Irish adults.  6 
Design: Folic acid and vitamin B-12 from fortified foods and supplements were estimated 7 
using brand information for participants from the cross sectional National Adult Nutrition 8 
Survey 2008-10. Dietary and biomarker values were compared across six mutually exclusive 9 
consumption groups formed on the basis of folic acid intake. 10 
Results: Consumption of folic acid through fortified foods at low, medium and high levels of 11 
exposure [median intakes (IQR) of 22 (13,32), 69 (56, 84) and 180 (137,248) µg/d 12 
respectively], supplements [203 (150,400) µg/d] or both [287 (220,438) µg/d] was associated 13 
with significantly higher folate intakes and status compared to non-consumption of folic acid 14 
(18% of the population). Median (IQR) red blood cell (RBC) folate increased significantly 15 
from 699 (538,934) nmol/L in non-consumers to 1040 (83, 1390) nmol/L in consumers with a 16 
high intake of fortified foods (P<0.001) with further non-significant increases in supplement 17 
users. Supplement use but not fortification was associated with significantly higher serum 18 
vitamin B-12 concentrations relative to non-consumers (P<0.001). Two thirds of young 19 
women had suboptimal RBC folate for protection against neural tube defects (NTDs); among 20 
non-consumers of folic acid only 16% attained optimal RBC folate. 21 
Conclusion: Consumption of voluntarily fortified foods and/or supplement use was 22 
associated with significantly higher dietary intakes and biomarker status of folate in Irish 23 
adults. Of concern, the majority of young women remain sub optimally protected against 24 
NTDs. 25 
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INTRODUCTION 26 
 27 
Folate has a well-established role in the prevention of NTDs (1, 2) and more recently, the 28 
metabolically related B vitamin, vitamin B-12 has also been shown to have a protective role 29 
independent of folate (3). Folate is available in the diet either in natural forms occurring in a 30 
variety of foodstuffs or in the synthetic form as folic acid which is present only in dietary 31 
supplements and fortified foods. Government bodies worldwide advise women of 32 
reproductive age to consume a daily folic acid supplement for NTD prevention. However, 33 
public health campaigns have been largely unsuccessful (4) and as a result some countries 34 
have opted for a policy of mandatory folic acid fortification of flour or bread alongside 35 
recommendations on supplement use. Mandatory fortification has been highly effective in 36 
reducing the number of NTD-affected pregnancies in these countries (5, 6). Nonetheless, 37 
certain concerns have been raised that the subsequent increase in folic acid intakes across all 38 
population subgroups may have unintended harmful effects on health such as masking of 39 
pernicious anaemia (7), colorectal cancer promotion in people with pre-existing lesions (8) or 40 
even incident cancer in elderly populations (9) or adverse cognitive effects in older adults 41 
with low vitamin B-12 status (10). Consequently, The US National Health and Nutrition 42 
Examination Survey has extended its monitoring programme to examine folic acid intakes 43 
and corresponding folate biomarker status from all sources of folic acid in the US diet 44 
including mandatory fortification, voluntary fortification and supplements (11).  45 
In the last decade, mandatory folic acid fortification has been considered by European 46 
countries including Ireland (12) and the United Kingdom (13) but to date remains non-47 
existent in Europe. In contrast, voluntary fortification with micronutrients including folic acid 48 
and vitamin B-12 is permitted in some countries, with Ireland considered to have one of the 49 
most liberal policies (14, 15). Currently, there is no routine monitoring in place to measure the 50 
impact of such voluntary fortification on micronutrient intakes and status, in part due to the ad 51 
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hoc nature of voluntary fortification and also due the aggregated presentation of all vitamin 52 
forms in European food composition tables (16). Moreover, supplement use is often not 53 
accounted for in national dietary surveys, nor are blood samples routinely collected for the 54 
measurement of biomarker status of folate, vitamin B-12 or other micronutrients.  55 
The Irish National Adult Nutrition Survey (NANS) 2008-2010 is one of the few 56 
national dietary surveys in Europe to have collected comprehensive brand level dietary intake 57 
data on both fortified foods and dietary supplements in addition to biomarker data on B 58 
vitamin status. Thus, it provides an excellent opportunity to assess the impact of voluntary 59 
fortification and supplement use in a nationally representative population exposed to a high 60 
level of voluntary fortification. The aims of this paper were therefore to evaluate dietary 61 
intakes and status of folate and vitamin B-12 in the Irish adult population and to examine the 62 
relative contribution of voluntary fortification and supplement use to these intakes and 63 
corresponding biomarkers.   64 
 65 
SUBJECTS AND METHODS 66 
 67 
Sampling Procedure 68 
Data for this analysis were derived from the NANS, a cross sectional food consumption 69 
survey carried out between May 2008 and April 2010 in the Republic of Ireland  in a national 70 
sample of 1500 adults aged 18-90 years (men: n = 760; women: n = 740). A detailed 71 
description of the methodology used in the NANS has been reported elsewhere (17). 72 
However, a concise overview of subject sampling and recruitment procedures, as well as 73 
methods of data collection and laboratory analysis pertinent to the objectives of the present 74 
work, are outlined below.  Ethical approval was obtained from University College Cork 75 
Clinical Research Ethics Committee of the Cork Teaching Hospitals and the Human Ethics 76 
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Research Committee of University College Dublin. Written consent was obtained from all 77 
participants in accordance with the Declaration of Helsinki.     78 
 As the Republic of Ireland does not have a national identification system for adults, a 79 
database of names and addresses held by Data Ireland (National Postal Service) was used to 80 
randomly select persons in twenty geographical clusters across the country, selected to 81 
provide proportional representation across the urban–rural continuum. A sample of 1500 free-82 
living adults to represent a population of over 4 million people participated in the dietary 83 
survey. The sample size was chosen to deliver at least 100 individuals in the least populated 84 
age and sex sub-groups. There were few exclusion criteria, other than pregnancy/lactation and 85 
inability to complete the survey due to disability. The sample was representative of the Irish 86 
adult population with respect to age, gender, social class and urban/rural location when 87 
compared to the 2006 Irish census (18). In addition to the collection of food and beverage 88 
intake data and blood samples for nutritional biochemistry, questionnaires were administered 89 
to collect data on socio-demographics (including education and social class) and health and 90 
lifestyle factors (including smoking status and medication usage) and anthropometric 91 
measures including height, weight, waist and hip circumference and body composition were 92 
measured in the participant’s homes (17). Participation in the survey did not require provision 93 
of a blood sample. The overall response rate of the survey which was calculated as the 94 
number of participants who completed the 4 day food diary divided by the total number 95 
selected was 59.6%. For the purpose of this paper, only participants who provided dietary 96 
intake data and had biochemical data on folate and vitamin B-12 status were included 97 
(n=1136). A further 10 participants who were receiving vitamin B-12 injections (n=4) or 98 
taking high dose folic acid (≥5mg) (n=6) were excluded resulting in a final sample size of 99 
1126.  100 
 101 
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Dietary Assessment  102 
Food and beverage intake data were collected using a 4 consecutive day semi-weighed food 103 
diary which included at least one weekend day. Participants were asked to record the type and 104 
amount of all food, beverages and supplements consumed and where applicable, record 105 
recipes, cooking method and details of leftovers. A quantification protocol developed by the 106 
Irish Universities Nutrition Alliance for the North/South Ireland Food Consumption Survey  107 
was updated for NANS and is described elsewhere (19). Participants recorded their food 108 
intake at brand level where possible and were asked to retain packaging of foods they 109 
consumed which was later used to develop the Irish Food and Ingredients Database version 110 
3.0 (INFID) (20). INFID is a multifaceted database recording detailed information (including 111 
nutritional content and ingredients list) from the packaging of branded foods and beverages 112 
consumed during NANS and previous food consumption surveys in Ireland. Food intake data 113 
were analysed using the food composition database WISP© version 3.0 (Tinuviel Software, 114 
Anglesey, UK) which uses data from McCance and Widdowson’s ‘The Composition of 115 
Foods’ sixth and fifth editions plus all nine supplemental volumes to generate nutrient intake 116 
as described elsewhere (17). Adjustments were made to the food composition database to take 117 
account of recipes, nutritional supplements, commonly consumed generic Irish foods and new 118 
foods on the market. All food and beverages consumed in NANS were grouped into one of 21 119 
food groups.          120 
 Folate and vitamin B-12 intakes from natural food sources and fortified foods were 121 
estimated using WISP©, customized for NANS as described above and further modified for 122 
the purposes of the current analysis in relation to folate and vitamin B-12 values.  WISP© 123 
provides compositional data on the total folate and vitamin B-12 content of foods but does not 124 
distinguish between the natural form of the vitamin and any synthetic form that may be added 125 
through fortification. Therefore, fortified foods containing folic acid and vitamin B-12 were 126 
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initially identified from the presence of the vitamin on the ingredients list using INFID, 127 
manufacturer’s websites or by supermarket audits. To distinguish between the natural folate 128 
and vitamin B-12 content and that which is added during fortification, manufacturers were 129 
contacted to determine how B vitamins are declared on their nutrition labels. The majority 130 
reported that the vitamin value on the label was a combination of the natural and synthetic 131 
forms of the vitamin. Therefore, the natural B vitamin content of each food was estimated 132 
from published food composition data (17) and subtracted from the total to determine the 133 
synthetic content. Existing fortified foods in the database were updated to reflect current 134 
levels of fortification and newly identified fortified foods were allocated a new food code.  135 
Apart from these modifications, WISP was also customized for the purpose of this paper to 136 
include the contribution of supplements. The vitamin content of supplements was obtained 137 
from INFID or directly from product labels.      138 
 Overall, five descriptors for folate and vitamin B-12 intakes were created and will be 139 
referred to throughout the paper as 1) Natural: Folate or vitamin B-12 naturally occurring in 140 
foods  2) Synthetic - fortified foods: Folic acid or crystalline vitamin B-12 added during 141 
fortification 3) Synthetic - supplements: Folic acid or crystalline vitamin B-12 used in 142 
supplement formulations, 4) Total synthetic: a combination of folic acid and vitamin B-12 143 
from fortified foods and supplements and 5) Total: a combination of natural and total 144 
synthetic intakes. Henceforth, both synthetic forms of folate will be referred to as folic acid. 145 
Dietary folate equivalents (DFE’s) were also calculated based on the following equation: 146 
Dietary folate equivalent (µg) = natural folate (µg) + 1.7 x added folic acid in foods (µg) (21). 147 
 148 
 149 
 150 
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Blood Sampling and Biomarker Analysis 151 
Participants who consented to give a blood sample were asked to attend a designated 152 
phlebotomy clinic within their area or for older adults who were unable to travel, the samples 153 
were collected in the participant’s’ home by a qualified phlebotomist. All participants were 154 
asked to fast from food, beverages and supplements overnight for 12hrs prior to their 155 
appointment the following morning. A total of 1136 respondents (75.7% of the total sample) 156 
successfully provided a blood sample, of which, 79% were fasting samples. The blood 157 
samples reached laboratories in University College Dublin or University College Cork within 158 
5 h of collection (time delays between 30 min and5 h) and were processed and stored at 159 
−80○C until required for further analysis. Red blood cell (RBC) folate, serum folate (22) and 160 
serum vitamin B-12 (23)
 were measured by microbiological assay and total plasma 161 
homocysteine (tHcy) was measured by florescence polarization immunoassay (24). Full blood 162 
counts were performed on the Beckman coulter counter from which packed cell volume was 163 
obtained for the calculation of RBC folate concentrations. The 5, 10 164 
methylenetetrahydrofolate reductase 677C→T genotype (MTHFR) (25) was determined by 165 
polymerase chain reaction amplification followed by Hin F1 restriction digestion which was 166 
carried out by LGC (www.lgcgroup.com). Samples were analysed blind for all assays and 167 
quality control was carried out by repeated analysis of stored batches of pooled samples 168 
covering a wide range of values. Intra- and inter-assay coefficients of variation were ≤10.9% 169 
for serum folate; ≤13.8% for RBC folate; ≤11.0% for serum vitamin B-12 and ≤7.3% for 170 
tHcy. 171 
 172 
Statistical Analysis 173 
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All statistical analyses were performed using PASW version 18 (SPSS Inc. Chicago, IL, 174 
USA). The distributions of all dietary variables and biomarkers were positively skewed; 175 
therefore the data were presented as medians and interquartile ranges. The n value was 176 
reduced slightly for analyses on biomarker variables to take account of missing data for some 177 
participants; serum folate (n=11), RBC folate (n=8), serum vitamin B-12 (n=12) and tHcy 178 
(n=10). A two-way ANOVA with scheffe post hoc tests was used to assess the impact of sex 179 
and age on biomarkers of folate and vitamin B-12 status. The relationships between dietary 180 
and biomarker variables were examined using Pearson’s correlation and Pearson’s partial 181 
correlation coefficients. To examine the relative impact of voluntary fortification and 182 
supplement use, participants were categorised into six mutually exclusive consumption 183 
groups formed according to their source of folic acid intake from the 4-day food diary. Non 184 
consumers consumed no folic acid during the food diary recording period. Fortified food 185 
consumers consumed a folic acid fortified food at least once during the recording period and 186 
were further stratified into low, medium and high consumers based on tertiles of folic acid 187 
intake.  Supplement users were defined as participants who consumed folic acid from a 188 
supplement at least once during the recording period, but no folic acid from fortified food. 189 
Supplement users and fortified food consumers consumed folic acid from both sources. As 190 
most vitamin B-12 fortified foods also contained folic acid and almost all consumers of 191 
vitamin B-12 supplements also consumed folic acid supplements, a separate analysis 192 
according to mutually exclusive vitamin B-12 consumption groups was not conducted; 193 
instead the fortified food and supplement consumption groups based on folic acid intakes 194 
were also applied to vitamin B-12.  Population characteristics were compared across 195 
consumption groups using chi square analysis for categorical variables and one-way ANOVA 196 
for continuous variables with scheffe post hoc tests. B vitamin intakes and biomarker 197 
concentrations were compared using ANCOVA with Bonferroni post hoc tests controlling for 198 
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sex, smoking, body mass index and energy intakes. In a similar sub analysis, the proportion of 199 
women of reproductive age with optimal RBC folate (>907nmol/L) and serum vitamin B-12 200 
status (>221pmol/L) for protection against NTDs (26, 3) were compared across five folic acid 201 
consumption groups using binary logistic regression adjusting for the MTHFR genotype and 202 
smoking status. For all statistical analyses, continuous variables were log transformed to 203 
normalise their distribution and P<0.05 was considered statistically significant. 204 
 205 
 206 
RESULTS 207 
The final sample comprised of 50% males and 50% females and included 67.7%, 19.7% and 208 
12.5% in the age groups 18-50, 51-64 and ≥65 years respectively. The majority of the sample 209 
were from an urban location (70%) and almost half (45%) were classified as professionals or 210 
in technical or managerial occupations. The final sample did not differ from the total recruited 211 
sample in terms of age, sex, education level and location and remained representative of the 212 
Irish population with respect to these demographics. (18). Furthermore, the use of folic acid 213 
or vitamin B-12 supplements was similar between those included in the present analysis 214 
(14%) and those participants who did not provide a blood sample (13%).There were no 215 
significant differences in biomarker concentrations between fasting (n=895) and non-fasting 216 
(n=231) participants, except for serum folate concentrations which were significantly higher 217 
in non-fasting participants [median (IQR) 31.6 (17.4, 40.4) nmol/L compared to 28.9 (15.6, 218 
36.1) nmol/L]. Removal of participants who provided non-fasting blood samples (21% of the 219 
overall sample) did not change the main findings and these participants were therefore 220 
included in the final analysis (Data not shown).  221 
 222 
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Folate and Vitamin B-12 Intakes in the Total Population  223 
Median intakes of DFEs, total folate, natural folate and total folic acid for the total population 224 
were 323μg/d, 312μg/d, 223μg/d and 64μg/d respectively with the lowest intakes of each form 225 
of folate reported among women aged 18-50yrs (Table 1). The majority of the population 226 
were consumers of folic acid fortified foods (79%) while the use of folic acid supplements 227 
ranged from 8% in older men (≥65y) to 20% in women aged 51-64y. The median intake of 228 
total vitamin B-12 was 4.2μg/d for the total population with a very small reported intake from 229 
fortified foods and supplements (0.3μg/d). When adjusted for energy intakes, intakes of both 230 
total and natural folate and total and natural vitamin B-12 increased significantly with age, 231 
which may be partially driven by the higher folic acid and synthetic vitamin B-12 intakes 232 
from fortified foods among older adult (≥65yrs) consumers (Supplemental Table 1). Among 233 
supplement users, females had significantly higher energy adjusted intakes of folic acid and 234 
vitamin B-12 from supplements than males (Supplemental Table 1).   235 
 Overall, natural food sources made the greatest contribution to mean intakes of total 236 
folate (74%) and vitamin B-12 (87%) (data not shown). Folic acid and vitamin B-12 from 237 
fortified foods (mainly from breakfast cereals and fat spreads) contributed 20% and 8% to 238 
total folate and vitamin B-12 intakes respectively while supplements contributed only 5-6% to 239 
total intakes of both vitamins (data not shown). 240 
 241 
Folate and Vitamin B-12 Status and Correlation with Dietary Intakes 242 
Median concentrations of RBC folate, serum folate, serum vitamin B-12 and tHcy were 243 
872nmol/L, 25.5nmol/L, 298pmol/L and 11.8µmol/L respectively for the total population 244 
(Table 2). A significant sex-by-age interaction was observed for serum vitamin B-12 245 
(P<0.001) whereby concentrations tended to decrease with age for men but increased with age 246 
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for women.  Overall, women had significantly higher concentrations of serum folate 247 
(P=0.016) compared to men while men had significantly higher concentrations of tHcy 248 
(P<0.001). Men and women aged ≥65yrs had significantly higher concentrations of RBC 249 
folate (P=0.001) and tHcy (P<0.001) compared to the youngest age group (18-50yrs). The 250 
proportion of the total population with low serum folate (<6.8nmol/L), low-marginal RBC 251 
folate (<453nmol/L) and vitamin B-12 (<148pmol/L) concentrations was < 2%, 6% and 7% 252 
respectively (Data not shown). Among consumers of fortified foods who did not consume 253 
folic acid supplements, RBC folate was significantly correlated with dietary folate intake 254 
expressed as DFEs (r=0.367; P<0.001), and was found to be more strongly correlated with 255 
added folic acid (r=0.309, P<0.001) than with natural food folate (r=0.175, P<0.001) (Figure 256 
1). Corresponding intake-status correlations for serum folate showed a similar pattern when 257 
intakes were expressed as DFE (r=0.417, P<0.001), added folic acid (r=0.396, P<0.001) or 258 
natural food folates (r=0.163, P<0.001). In non-consumers of vitamin B-12 supplements, 259 
serum vitamin B-12 was weakly though significantly correlated with vitamin B-12 intake, 260 
both total (including fortified food) and natural vitamin B-12 intake only (r=0.190 and 0.166 261 
respectively; P<0.001) (Figure 2).  262 
 263 
B Vitamin Dietary Intakes and Biomarker Status according to Intakes of Folic Acid 264 
Fortified Foods and Supplements 265 
Almost one fifth (18%) of the population reported consuming no folic acid from either 266 
fortified foods or supplements (group 1) while the majority (68%) consumed folic acid from 267 
fortified foods only (groups 2-4) (Table 3). Among supplement users, 3% did not consume 268 
fortified foods (group 5) while 11% also consumed folic acid from fortified foods (group 6). 269 
No significant differences across consumption groups in terms of social class, education, 270 
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location, MTHFR 677C→T genotype and fasting status were observed but there were 271 
significant differences in sex, energy intake, smoking status (P<0.001) and BMI (P<0.05). 272 
Intakes of natural folate did not differ significantly across the consumption groups (P=0.366); 273 
however, there was a significant stepwise increase in total folate and folic acid intakes with 274 
increasing intake of fortified foods and with supplement use (P<0.001). The dietary intake 275 
pattern was typically reflected in serum folate (P<0.001) and RBC folate (P<0.001) but 276 
concentrations of both reached a plateau among high fortified food consumers with no further 277 
significant increases in supplement users. The pattern was less marked for vitamin B-12  as 278 
only supplement users had a significantly higher concentration of serum vitamin B-12 279 
compared to non-consumers (P<0.001). Concentrations of tHcy were 1-2μmol lower among 280 
medium and high fortified food consumers and supplement users compared to non-consumers 281 
and low fortified food consumers (P<0.001). Only 3 participants had an intake of folic acid 282 
exceeding the tolerable upper level (1,000µg/d); of which, one participant was a high fortified 283 
food consumer and two were supplement users only. The prevalence of high serum folate 284 
concentrations (>45nmol/L) was 4%, 8%, 10%, 34%, 28% and 50% across consumption 285 
groups 1-6 respectively (Data not shown).      286 
 Overall, only 36% of women of reproductive age (134 out of 371) achieved an optimal 287 
folate status for NTD protection (>907nmol/L), of which, a significantly higher proportion 288 
were in the high fortified food consumer group (47%) and supplement user group (64%) 289 
compared to the other three groups (16-33%) (P=0.008) (Figure 3). An optimal serum 290 
vitamin B-12 concentration (>221pmol/L) was observed for 70% of women and there was no 291 
significant difference in the proportion achieving this concentration across the consumption 292 
groups (Figure 3). 293 
 294 
 295 
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DISCUSSION   296 
The results showed that consumption of voluntarily fortified foods and supplements were 297 
each associated with significantly higher biomarker status of folate in a nationally 298 
representative sample of Irish adults. Nevertheless, their population impact was unevenly 299 
distributed and current biomarker concentrations of folate were deemed insufficient to 300 
adequately protect the majority of women of reproductive age against NTDs. In the case of 301 
vitamin B-12, only supplement use was associated with improved biomarker status.  These 302 
outcomes could help inform the international debate on mandatory folic acid fortification and 303 
assist in the establishment of evidence-based dietary reference values for folate.  304 
 Similar to a recent Irish study (27), we observed an adequate folate status and a low 305 
prevalence of clinical deficiency in the general population. This could be partially attributed 306 
to an increase in voluntary fortification practices in Ireland as our results show an increase 307 
both in the number of consumers (from 67% to 79%) and total folate intakes (by ≈ 50µg/d) 308 
over the past decade (28). As per similar studies in Northern Ireland (29) and the US (11), 309 
with increased consumption of folic acid from fortified foods there was a significant increase 310 
in RBC folate status, a long term measure of folate status.  Furthermore, the magnitude of 311 
increase in RBC folate status (26%) between the ‘medium’ (825nmol/L) and ‘high’ 312 
(1040nmol/L) folic acid consumer groups was similar to that estimated for a doubling of 313 
supplemental doses in the range of 50-400µg/d (30). Moreover, high fortified food consumers 314 
(median intake 180µg/d) had similar RBC folate and tHcy concentrations to that of 315 
supplement users, supporting previous research showing the effectiveness of chronic low dose 316 
folic acid intake in improving RBC folate status (31, 32), and lowering tHcy concentrations 317 
(33). Also, of note, high fortified food consumers in the current study had comparable serum 318 
folate and RBC folate concentrations to non-supplement users in the US (34). Collectively, 319 
these observations support the view that chronic low dose folic acid consumption from 320 
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voluntary fortification has the potential to be as effective as both supplement use and 321 
mandatory fortification, at least when mean folate values are considered. The notable 322 
difference between mandatory and voluntary fortification however, is that the impact of the 323 
latter will be entirely dependent on individual food choices, and the much lower folate status 324 
of non-consumers of fortified foods (compared with mean population folate values) may have 325 
been overlooked previously.  The current results showed that non-consumers of folic acid 326 
from fortified food or supplements (18% of the Irish population) were at much greater risk of 327 
suboptimal folate status compared with the population as a whole.  Of greatest concern, the 328 
majority of young women (66%) in the present study had suboptimal RBC folate for 329 
maximum protection against NTDs (26) and this was most evident among non-consumers of 330 
folic acid (84%), thus highlighting the disproportionate efficacy of voluntary fortification as a 331 
public health measure to prevent NTD. Furthermore, only 16% of young women reported use 332 
of folic acid supplements. These findings would therefore support the view that mandatory 333 
fortification is the only way to ensure some protection to all women against NTDs. 334 
 Recently, a competent authority in Ireland has advised against further increases in 335 
voluntary folic acid fortification (35) which may be driven by concerns related to the potential 336 
adverse health effects of high folic acid intakes.  In the present study, folic acid intakes 337 
exceeding the tolerable upper level (1,000µg/d) were only evident in 0.2% of the population 338 
(n=3) and the 95th percentile of intake was 437µg/d in high fortified food consumers ,733 339 
µg/d in consumers of supplements only and 1320µg/d in consumers of both. This indicates 340 
that supplement use was more likely to contribute to intakes above the tolerable upper level 341 
rather than fortification, which is in agreement with data from the US and Canada (11, 36). 342 
The significance of high serum folate concentrations (>45nmol/l) detected in 19% of the 343 
population is unclear but it has been correlated with unmetabolised folic acid in plasma (37) 344 
which in turn has been hypothesised to mediate some of the adverse effects associated with 345 
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high folic acid (9). In the interim, continued monitoring of folic acid intakes from voluntary 346 
fortification is warranted while further analysis of this cohort could establish baseline levels 347 
of unmetabolised folic acid in Irish adults.        348 
 The intake-status data presented in the current study will be of high relevance for 349 
international bodies tasked with setting dietary reference values for folate.  It has been 350 
recommended that consideration be given to differences in bioavailability in folate and folic 351 
acid when establishing dietary recommendations, chiefly through the use of DFE (38). 352 
Indeed, this is the approach used currently in the US (21) and recently proposed by the 353 
European Food Safety Authority (EFSA) (39).  Our intake-status data, showing that natural 354 
food folate compared to added folic acid was poorly correlated with folate status biomarkers 355 
(whether  RBC or serum folate) , confirms the relatively greater bioavailability of the latter 356 
(40). Therefore the use of the DFE to express folate intake (which inherently adjusts for the 357 
higher bioavailability of added folic acid compared to natural food folate; 21) is more 358 
appropriate than the alternative approach, of disregarding differences in folate bioavailability 359 
and treating natural food folates and added folic acid equally when considering dietary intakes 360 
or setting dietary reference values.          361 
 Although vitamin B-12 fortified foods were consumed by 65% of the population, their 362 
impact on vitamin B-12 status was minimal with only supplement use having a significant 363 
effect as reported elsewhere (11, 29, 41).  The low level of vitamin B-12 supplement use and 364 
the low concentration of vitamin B-12 used in fortified products in Ireland may have 365 
implications for women of reproductive age as almost one third had a vitamin B-12 366 
concentration below 221pmol/l exposing them to greater NTD risk (3). Older adults are also 367 
an “at risk” group due to the well recognized problem of food-bound B-12 mal-absorption. 368 
The higher vitamin B-12 status among older women compared to men may be explained by 369 
their higher intake of crystalline vitamin B-12 from supplements. Thus, more targeted dietary 370 
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recommendations and health promotion campaigns may be required for these subgroups and 371 
consideration by policymakers of vitamin B-12 fortification as well as folic acid.  372 
 One of the main strengths of this study is the nationally representative nature of the 373 
sample and the collection of detailed dietary data (to brand level) which facilitated the 374 
estimation of synthetic vitamin intakes from fortification and supplement use. Additionally, 375 
the measurement of RBC folate using the microbiological assay is considered as the gold 376 
standard method for measuring long term folate status (42). Under- or over-estimation of 377 
intakes was possible given the cross-sectional nature of the study and the reliance on nutrient 378 
information from food labels with no account for overage. Of note, the number of adults who 379 
consumed supplements only and not fortified foods (n=36) was relatively small compared to 380 
the other consumption groups, therefore conclusions related to supplement use only should be 381 
interpreted with caution. Furthermore, the creation of the consumption groups were based on 382 
the consumption of folic acid fortified foods and supplements rather than vitamin B-12. The 383 
main results, however, remained unchanged when grouped by vitamin B-12 (data not shown). 384 
The lack on data on methylmalonic acid (MMA) which is considered a more specific 385 
functional marker of vitamin B-12 status may have been a further limitation; however, MMA 386 
is specific only at concentrations indicative of deficiency (43).    387 
 In conclusion, voluntary fortification and supplement use in Ireland were each 388 
associated with significantly improved dietary intakes and biomarker status of folate in the 389 
general population, but their impact was inadequate in providing the majority of women of 390 
reproductive age an optimal RBC folate concentration to protect against NTDs. These folate 391 
and vitamin B-12 intake-status data will serve as an important population-based baseline 392 
against which future changes in fortification practices and supplement use in Ireland can be 393 
monitored. Furthermore, it should help inform future policy decisions in countries now 394 
considering fortification.  395 
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Table 1. Median intakes of folate and vitamin B-12 according to dietary source in the total population and percentage consumers of fortified foods 
and supplements by sex and age group 
  All Ages   Males   Females  
 18-91y  18-50y 51-64y ≥ 65y  18-50y 51-64y ≥ 65y  
 (n=1126)  (n=392) (n=112) (n=63)  (n=371) (n=110) (n=78)  
           
Folate intakes (µg/d)           
DFE   323 (234, 474)1  389 (294, 554) 409 (292, 580) 356 (233, 581)  267 (197, 363) 303(230, 464) 269 (210, 451)  
Total2  312 (228, 448)  372 (280, 506) 351 (265, 497) 314 (214, 470)  260 (192, 349) 297 (225, 423) 277 (198, 391)  
   Natural   223 (173, 286)  274 (204, 344) 271 (213, 325) 223 (184, 274)  189 (151, 231) 207 (171, 268) 210 (158, 248)  
   Total folic acid3   64 (14, 167)  74 (20, 175) 68 (9, 205) 71 (12, 183)  52 (13, 135) 66 (24, 196) 63 (12, 177)  
         Fortified foods4   50 (9, 118)  58 (12, 125) 60 (8, 169) 64 (11, 180)  35 (6, 87) 40 (9, 109) 47 (0, 138)  
           
Consumers of folic acid (%)           
Fortified foods   79  80 80 81  78 80 74  
Supplements  14  14 9 8  16 20 14  
           
           
Vitamin B-12 intakes (µg/d)           
Total2  4.2 (2.9, 6.1)  5.0 ( 3.4, 7.0) 4.8 (3.3, 6.9) 4.8 (2.9, 6.6)  3.5 (2.4, 4.8) 4.2 (3.2, 6.0) 4.1 (2.8, 5.6)  
    Natural  3.7 (2.5, 5.1)  4.3 (3.0, 5.9) 4.4 (2.8, 6.1) 4.2 (2.8, 5.6)  2.9 (2.0, 4.0) 3.8 (2.7, 4.8) 3.7 (2.7, 4.8)  
    Total synthetic3  0.3 (0, 0.8)  0.3 (0.0, 0.8) 0.2 (0.0, 0.9) 0.2 (0.0, 1.2)  0.2 (0.0, 0.7) 0.3 (0.0, 0.9) 0.2 (0.0, 0.8)  
         Fortified foods4  0.1 (0.0, 0.5)  0.2 (0.0, 0.5) 0.2 (0.0, 0.8) 0.2 (0.0, 1.0)  0.1 (0.0, 0.4) 0.1 (0.0, 0.5) 0.1 (0.0, 0.4)  
           
Consumers of synthetic  B-12 (%)           
Fortified foods  65  67 63 65  64 63 60  
Supplements  14  14 7 8  15 19 14  
1Interquartile range in parentheses (all such values)                  
2Refers to total folate or vitamin B-12 intakes from natural food sources, fortified foods and supplements.      
3Refers to total folic acid and total synthetic vitamin B-12 intakes from both fortified foods and supplements.       
4 Refers to folic acid and synthetic vitamin B-12 intakes from fortified foods only. Intakes from supplements are not given for the total population due to the low percentage of consumers. 
DFE, dietary folate equivalents calculated as follows: natural folate (µg) + (folic acid from fortified foods (µg) x 1.7) (21)      
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Table 2. Effects of sex and age on median concentrations of red blood cell folate, serum folate, serum vitamin B-12  and total plasma 
homocysteine in Irish adults   
  All ages      Age group  2-way ANOVA1  
 n 18-91y  n 18-50y n 51-64y n  ≥65y (P-value)  
           Sex Age  S X A  
RBC folate (nmol/L)               
All 1118 872 (672, 1196)2  756 839 (660, 1137)a 221 924 (700, 1269)ab 141  960 (747, 1356)b 0.509 0.001 0.126  
Males 563 923 (707, 1171)  388 905 (700, 1154) 112 924 (713, 1228) 63  964 (740, 1414)     
Females 555 836 (649, 1228)  368 799 (626, 1110) 109 936 (696, 1334) 78  926 (747, 1296)     
               
Serum folate (nmol/L)               
All 1115 25.5 (16.7, 38.8)  756 24.9 (16.6, 36.0)a 220 28.2 (17.9, 42.9)b 139  28.0 (16.0, 46.3)ab 0.016 0.032 0.071  
Males 560 24.9 (17.1, 36.7)  387 24.4 (17.0, 35.5) 110 24.8 (16.9, 38.5) 63  30.2 (19.2, 38.6)     
Females 555 26.1 (16.4, 41.2)  369 25.2 (16.1, 37.2) 110 32.0 (18.9, 47.8) 76  27.0 (14.1, 54.9)     
               
Serum vitamin B12 (pmol/L)              
All 1114 298 (224, 378)  756 305 (226, 379) 220 285 (217, 383) 138  277 (216, 369) 0.259 0.475 <0.001  
Males 559 314 (238, 388)  387 328 (257, 403) 110 295 (209, 383) 62  247 (205, 322)     
Females 555 289 (215, 369)  369 285 (205, 360) 110 282 (228, 400) 76  306 (250, 387)     
               
tHcy (µmol/L)               
All 1116 11.8 (10.1, 13.8)  756 11.4 (9.8, 13.1)a 219 12.4 (10.8, 14.8)b 141  13.2 (11.1, 15.8)b <0.001 <0.001 0.866  
Males 562 12.4 (10.8, 14.4)  388 12.0 (10.4, 13.7) 111 13.2 (11.5,15.4) 63  13.9 (11.7, 17.3)     
Females 554 11.1 (9.5, 12.9)  368 10.7 (9.3, 12.3) 108 11.7 (10.2, 14.3) 78  12.2 (10.4, 15.5)     
                             
1Main effects and interaction effects were assessed by two way ANOVA.          
2Interquartile range in parentheses (all such values)             
abcValues across a row with unlike superscript letters are significantly different (scheffe post hoc test) P < 0.05        
A, age; RBC, red blood cell; S, sex; tHcy, total plasma homocysteine           
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Table 3. Dietary intakes and biomarker status of folate and vitamin B-12 grouped by participants' intake of  folic acid fortified foods and supplements1 
  
Non         
Consumers                    
(1) 
Low                             
Consumers           
(2) 
Medium 
Consumers           
(3) 
High                         
Consumers                  
(4) 
Supplement                      
users                    
(5) 
Supplement users 
& FF consumers 
(6) 
P-
value2 
Folic acid intake 0µg/d 1-45µg/d 46-108µg/d 109-1044µg/d 10-2,000µg/d 33-958µg/d   
n 200 254 252 261 36 123  
General Characteristics        
Male:female (%) 48:52 43:57 52:48 62:38 42:58 43:57 <0.001 
Age (y) 45 (31, 56)3 43 (28, 55) 39 (27, 52) 45 (28.5, 58) 38 (27,52) 38 (26,57) 0.056 
BMI (kg/m2) 27.1 (23.7, 30.1) 26.6 (23.8, 29.9) 26.6 (23.8, 30.1) 26.3 (23.7, 29.1) 25.6 (22.9,28.3) 25.3 (22.8,28.2) 0.037 
Energy (MJ/d) 7.9 (6.5, 9.7)a 7.9 (6.2, 9.7)a 8.2 (6.4, 10.6)ab 9.0 (7.2, 11.3)b 8.7 (6.8, 10.5)ab 8.6 (7.2, 11.2)ab <0.001 
Smoker (%) 30 23 20 12 19 13 <0.001 
Dietary Intakes        
Folate (µg)        
Total  206 (160, 293)a 233 (186, 291)b 288 (242, 349)c 445 (363, 535)d 558 (267, 636)de 582 (431, 746)e <0.001 
  Natural  206 (160, 293) 211 (161, 272) 214 (170, 278) 248 (195, 309) 237 (179, 306) 246 (185, 309) 0.366 
  Folic acid 0.0 22 (13, 32)a 69 (56, 84)b 180 (137, 248)c 203 (150, 400)cd 287 (220, 438)d <0.001 
DFE 206 (160, 293)a 249 (199, 310)b 338 (291, 406)c 572 (472, 709)d 237 (179,306)ab 373 (252, 546)e <0.001 
Vitamin B-12 (µg)        
Total  3.4 (2.4, 4.9)a 3.6 (2.3, 4.8)a 3.9 (2.8, 5.4)a 4.8 (3.6, 6.3)b 8.0 (5.4, 24.7)c 7.2 (4.9, 12.2)d <0.001 
  Natural  3.4 (2.4, 4.8) 3.4 (2.1, 4.6) 3.6 (2.4, 5.1) 4.0 (2.9, 5.5) 4.2 (3.2, 5.4) 4.3 (2.8, 5.4) 0.012 
  Synthetic  0.0 0.05 (0, 0.1)a 0.3 (0.2, 0.4)b 0.7 (0.4, 1.1)c 2.9 (1.0, 17.6)d 2.0 (1.1, 6.5)e <0.001 
Biomarkers        
Serum folate (nmol/L) 17.0 (12.3, 24.8)a 21.7(14.2, 30.3)b 23.2 (16.8, 33.1)b 36.9 (26.3,53.6)c 32.9 (22.6, 48.1)c 44.9 (29.2, 68.6)c <0.001 
RBC folate (nmol/L) 699 (538, 934)a 784 (623, 1018)b 825 (695, 1083)b 1040 (83, 1390)c 1013 (812, 1487)c 1156 (831, 1501)c <0.001 
Serum vitamin B-12 (pmol/L) 288 (202, 357)
ab 261 (197, 343)a 296 (239, 368)ab 315 (252, 410)bc 380 (295, 497)cd 373 (287, 485)d <0.001 
Plasma tHcy (µmol/L) 12.7 (11.0, 15.5)a 12.2 (10.7, 14.5)a 11.9 (10.2, 13.9)b 11.5 (9.7, 12.9)bc 10.6(9.6, 13.0)abc 10.3 (9.2, 12.2)c <0.001 
1Non consumers (1) consumed no folic acid from fortified foods or supplements during the food diary. Those who consumed folic acid from fortified foods at least once during the food diary were 
categorised as low (2) medium (3) or high (4) consumers based on tertiles of folic acid intake from fortified foods. Supplement users (5) consumed folic acid from supplements at least once during 
the food diary and no fortified foods.  Supplement users and fortified consumers (6) consumed folic acid from both supplements and fortified foods.   
2General characteristics were compared across the groups using Chi square analysis and one-way ANOVA (scheffe post hoc tests). B vitamin dietary intakes and biomarkers were compared using 
one-way ANCOVA controlling for gender, BMI, energy intakes and smoking status. abcValues across a row with unlike superscript letters were significantly different (bonferroni post hoc tests). P 
<0.05. 
3Median and interquartile range in parentheses (all such values).      
DFE, dietary folate equivalents calculated as follows: natural folate (µg) + (folic acid from fortified foods (µg) x 1.7) (21); MJ, megajoule; RBC, red blood cell; tHcy, total plasma homocysteine. 
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Figure 1 
Relation between RBC folate concentration and dietary folate intake expressed as dietary folate 
equivalents (panel 1 a), added folic acid (panel 1 b) and natural folate only (panel 1 c) in fortified 
food consumers who were non-users of folic acid supplements. Correlations were calculated on 
log transformed data using Pearson’s correlation coefficients (r). P<0.05 was considered 
significant. Dietary folate equivalents were calculated as µg natural folate + [1.7 x added folic 
acid (µg) in foods] (20). Corresponding intake-status correlations for serum folate were: with 
DFE (r=0.417, P<0.001); added folic acid (r=0.396, P<0.001); natural food folates (r=0.163, 
P<0.001); n=757. For all correlations, one participant with an outlying intake value was 
removed from the analysis on the basis that the estimated intake was considered highly unlikely 
to be representative of true intake from food sources (i.e. DFE=2400 µg/d) 
 
Figure 2 
Relation between serum vitamin B-12 concentration and total dietary vitamin B-12 intake 
(panel 2 a) and natural vitamin B-12 intake (panel 1 b) in non-users of vitamin B-12 
supplements (representing 86% of the population). Correlations were calculated on log 
transformed data using Partial Pearson’s correlation coefficients (r) controlling for age. P<0.05 
was considered significant. Two participants with outlying vitamin B-12 intake values 
(36.9µg/d and 33.4 µg/d) and one participant with an outlying serum vitamin B-12 
concentration (2216pmol/L) were removed from the analysis.  
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Figure 3 
Proportion of women of reproductive age (18-50ys) with optimal folate (≥907nmol/L) (26) and 
vitamin B-12 status (>221pmol/L) (3) for protection against NTDs according to intake of folic 
acid fortified foods and supplements. Non-consumers consumed no folic acid during food diary. 
Those who consumed folic acid from fortified foods during the food diary but not supplements 
were stratified into tertiles of folic acid intake; low consumers (1-33μg/d), medium consumers 
(34-86μg/d) and high consumers (≥87μg/d). Supplement users consumed folic acid 
supplements during the food diary. As the majority of supplement users also consumed fortified 
foods (48 out of 58), they were merged into one group. Median RBC folate concentrations were 
638, 705, 775, 859 and 1233nmol/L across non consumers, low, medium and high consumers 
and supplements users respectively. The proportion of women with an optimal folate and 
vitamin B-12 status was compared across consumption groups using binary logistic regression 
controlling for smoking status and MTHFR genotype. ‡Denotes significantly different from 
non-consumers, low and medium consumers; †Denotes significantly different from non-
consumers (Bonferonni post hoc test) P<0.05. MTHFR, methylene tetrahydrofolate reductase, 
NTD, neural tube defect, RBC, red blood cell. 
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